Here's Why You Should Add Cencora Stock to Your Portfolio Now
11/7 14:02
COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks....
11/7 14:02
COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks....